Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Shareholder Meeting: fatwollit
2
Oct 01, 2007 06:33PM
3
Oct 01, 2007 07:00PM
9
Oct 01, 2007 07:11PM
4
Oct 01, 2007 07:52PM

Oct 01, 2007 08:30PM

Oct 01, 2007 09:18PM

Thanks. If you could dig up the questions, I would appreciate looking at them.

My concern is that after SHM, some of the questions that pop up here, will not be addressed. This is a frustration; that important questions are never addressed. I believe 100% that we cannot and should not direct PTSC; however, the ideas result in questions and this is what I'm getting at. Shareholders should not only want to present themselves as knowledgeable on what the company is trying to do but to come away with some insight that they didn't have before.

David Pohl's administration was about making the MMP a powerful revenue stream. How far are we from developing another significant revenue stream? There are hundreds of excellent questions to be asked, especially financial questions that will impact our future. What are the ideas of the new CFO on acquisition? What will it take to accomplish this acquisition?

Thanks for your interest, fatwollit (be sure to give him your list) 

1
Oct 02, 2007 09:02AM
Share
New Message
Please login to post a reply